Among the twelve peptides removed from the Category 2 list (effective April 23, 2026): Removal from Category 2 is separate from the FDAs review of which peptides may be compounded under section 503A
The COA confirms compound identity, purity at 99%+, and the absence of truncated sequences
If you miss a dose, take it when you remember unless it is almost time for your next scheduled dose
The enhanced cellular uptake results in higher intracellular concentrations of glutathione, where it can exert its antioxidant and detoxifying effects more effectively
Any form of introduction into the human or animal body is illegal
Researchers are advancing peptide stability and delivery through altered sequences, carriers, and non-oral routes to increase safety and effectiveness